DRKS00028174已完成不适用
Immune response against SARS-CoV-2 vaccination
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- DKFZ
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •healthy who can give informed consent
排除标准
- •Volunteers who suffer from chronic or acute direct (infections, autoimmunity, tumors, congenital) or indirect (drug induced) immune defects
研究者
相似试验
进行中（未招募）
1 期
SARS-CoV-2 immune responseimmune response to COVDI-19 vaccinationEUCTR2021-001202-30-NLDiakonessenhuis400
招募中
4 期
Efficacy of vaccine responses against SARS-Cov-2 in patients with giant cell arteritis and polymyalgia rheumatica (GPSVAC)NL-OMON51139niversitair Medisch Centrum Groningen80
尚未招募
不适用
Response rate to SARS-CoV-2 (COVID-19) vaccine in dialysis patients.JPRN-UMIN000043368agasaki University110
招募中
不适用
SARS-CoV-2 immune responseCOVID-1910047438NL-OMON55057Diakonessenhuis Utrecht800
已完成
Unknown
Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients on Disease-Modifying DrugsMultiple SclerosisJPRN-UMIN000049478Osaka University Department of Neurology, Osaka University Graduate School of Medicine50